Literature DB >> 2529936

Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion.

D B Northridge1, J McMurray, S Ray, A Jardine, H J Dargie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529936      PMCID: PMC1837471          DOI: 10.1136/bmj.299.6699.603

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.

Authors:  B S Edwards; R S Zimmerman; T R Schwab; D M Heublein; J C Burnett
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

2.  Paradoxical response of plasma atrial natriuretic hormone to pericardiocentesis in cardiac tamponade.

Authors:  P T Koller; R J Grekin; J M Nicklas
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

3.  Release of atrial natriuretic factor after pericardiectomy for chronic constrictive pericarditis.

Authors:  M W Wolozin; F V Ortola; D H Spodick; J L Seifter
Journal:  Am J Cardiol       Date:  1988-12-01       Impact factor: 2.778

4.  Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

Authors:  A M Richards; G Tonolo; G D McIntyre; B J Leckie; J I Robertson
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

Review 5.  The atrial peptide system in cardiac disease.

Authors:  J C Burnett
Journal:  Am J Hypertens       Date:  1988-10       Impact factor: 2.689

  5 in total
  2 in total

1.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22

2.  Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.

Authors:  M Riley; J S Elborn; G Onuoha; C Erwin; C Shaw; M M Khan; C F Stanford; D P Nicholls
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.